Cargando…
The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients
In this prospective, case-control genetic study, 120 consecutive neovascular age-related macular degeneration (AMD) cases and 78 controls were enrolled. Two SNPs (rs2071559 and rs1870377) of VEGF-A receptor-2 (VEGFR-2) gene were analyzed with the technique of Real-Time PCR to investigate a genetic l...
Autores principales: | Lazzeri, Stefano, Orlandi, Paola, Figus, Michele, Fioravanti, Anna, Cascio, Elisa, Di Desidero, Teresa, Agosta, Elisa, Canu, Bastianina, Sartini, Maria Sole, Danesi, Romano, Nardi, Marco, Bocci, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific World Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415178/ https://www.ncbi.nlm.nih.gov/pubmed/22919317 http://dx.doi.org/10.1100/2012/420190 |
Ejemplares similares
-
Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
por: Yuan, Yazhen, et al.
Publicado: (2023) -
Association of the rs2071559 (T/C) polymorphism with lymphatic metastasis in patients with nasopharyngeal carcinoma
por: Hu, Kai, et al.
Publicado: (2017) -
Genetic interaction of P2X(7) receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients
por: Solini, Anna, et al.
Publicado: (2015) -
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
por: Allegrini, Giacomo, et al.
Publicado: (2012) -
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide
por: Orlandi, P, et al.
Publicado: (2013)